Table 2. Tuberculosis prevalence (n = 1,011).
Variables | Total (n = 1,011) | HIV− (n = 491) | Newly Diagnosed HIV+ (n = 243) | Known HIV+ (n = 277) |
Smear result | ||||
n (%) overall positive | 20 (2.0%) | 11 (2.2%) | 8 (3.3%) | 1 (0.4%) |
n (%) scanty | 3 (0.3%) | 1 (0.2%) | 2 (0.8%) | 0 (0.0%) |
n (%) 1+ | 6 (0.6%) | 3 (0.6%) | 2 (0.8%) | 1 (0.4%) |
n (%) 2+ | 6 (0.6%) | 4 (0.8%) | 2 (0.8%) | 0 (0.0%) |
n (%) 3+ | 5 (0.5%) | 3 (0.6%) | 2 (0.8%) | 0 (0.0%) |
Culture result | ||||
n (%) negative | 746 (73.8%) | 346 (70.5%) | 180 (74.1%) | 220 (79.4%) |
n (%) contaminated | 162 (16.0%) | 88 (17.9%) | 36 (14.8%) | 38 (13.7%) |
n (%) MOTT | 47 (4.7%) | 31 (6.3%) | 9 (3.7%) | 7 (2.5%) |
n (%) M. tuberculosis | 56 (5.5%) | 26 (5.3%) | 18 (7.4%) | 12 (4.3%) |
Median (IQR) days to culture positivity | 13.5 (8–22) | 12 (7–17) | 13 (8–22) | 19 (14.5–27) |
MOTT, mycobateria other than TB.